Covidien (COV) announces the acquisition of privately-help CV Ingenuity for an undisclosed...

|By:, SA News Editor

Covidien (COV) announces the acquisition of privately-help CV Ingenuity for an undisclosed amount. CV Ingenuity's key asset - still in investigational phase - is a Drug Coated Balloon platform for treating peripheral arterial disease. (PR)